Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07138677
NA
Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial
Sponsor: Anhui Medical University
View on ClinicalTrials.gov
Summary
Estimate the safty and efficacy of personalized network neuronavigated transcranial magnetic stimulations in early Alzheimer's disease patients
Official title: The Safty and Efficacy of Mild Cognitiive Impairment Network Guided Transcranial Magnetic Stimulations for Patients With Early Alzheimer's Disease (SENS-eAD): A Randomized, Double-blind Trial
Key Details
Gender
All
Age Range
45 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-07-20
Completion Date
2025-12-30
Last Updated
2025-09-15
Healthy Volunteers
No
Interventions
OTHER
transcranial magnetic stimulation
Neuronavigated Theta-Burst Transcranial Magnetic Stimulation
Locations (1)
Anhui Medical University
Hefei, Anhui, China